Dosage form containing promethazine and another drug
    3.
    发明申请
    Dosage form containing promethazine and another drug 审中-公开
    含有异丙嗪和另一种药物的剂型

    公开(公告)号:US20050232986A1

    公开(公告)日:2005-10-20

    申请号:US10736902

    申请日:2003-12-17

    摘要: A pharmaceutical dosage form which comprises promethazine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of promethazine or salt thereof. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

    摘要翻译: 包含异丙嗪和/或其药学上可接受的盐和至少一种第二种药物的药物剂型。 所述剂型在所述至少一种第二药物的治疗范围内提供血浆浓度,所述血浆浓度在与所述剂型在异丙嗪或其盐的治疗范围内提供血浆浓度的相当长的一段时间内共同延长的时期内。 该摘要既不旨在限定本说明书中公开的发明,也不旨在以任何方式限制本发明的范围。

    Dosage form containing promethazine and another drug
    7.
    发明申请
    Dosage form containing promethazine and another drug 审中-公开
    含有异丙嗪和另一种药物的剂型

    公开(公告)号:US20050232993A1

    公开(公告)日:2005-10-20

    申请号:US11115293

    申请日:2005-04-27

    摘要: A pharmaceutical dosage form which comprises promethazine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of promethazine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

    摘要翻译: 包含异丙嗪和/或其药学上可接受的盐和至少一种第二种药物的药物剂型。 所述剂型在所述至少一种第二药物的治疗范围内提供血浆浓度,所述血浆浓度在与所述剂型在异丙嗪或其盐的治疗范围内提供血浆浓度的相当长的一段时间内共同延长的时期内。 本摘要既不旨在限定本说明书中公开的发明,也不旨在以任何方式限制本发明的范围。

    Dosage form containing carbetapentane and another drug
    9.
    发明申请
    Dosage form containing carbetapentane and another drug 审中-公开
    含有卡巴坦和另一种药物的剂型

    公开(公告)号:US20060029664A1

    公开(公告)日:2006-02-09

    申请号:US10910806

    申请日:2004-08-04

    IPC分类号: A61K9/20

    CPC分类号: A61K9/209 A61K9/0095

    摘要: A pharmaceutical dosage form which comprises carbetapentane and/or a pharmaceutically acceptable salt thereof and an additional drug. The dosage form provides a plasma concentration within the therapeutic range of the additional drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of carbetapentane. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

    摘要翻译: 包含碳代戊烷和/或其药学上可接受的盐和另外的药物的药物剂型。 所述剂型在额外药物的治疗范围内提供血浆浓度,所述时间段与至少约70%的剂型共同延长的时间段内,所述剂型在该时间段内提供血浆浓度在碳卡巴坦的治疗范围内。 该摘要既不旨在限定本说明书中公开的发明,也不旨在以任何方式限制本发明的范围。